Latest Articles

Publication Date
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer - Nature

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer Nature

Published: April 17, 2025, 12:18 p.m.
Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer - Physician's Weekly

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer Physician's Weekly

Published: April 17, 2025, 10:41 a.m.
Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer - Cureus

Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer Cureus

Published: April 17, 2025, 6:27 a.m.
Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study - Cureus

Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study Cureus

Published: April 16, 2025, 6:31 a.m.
Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets - Frontiers

Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets Frontiers

Published: April 15, 2025, 3:08 p.m.
Endometrial cancer: Kimberly's story - Roswell Park Comprehensive Cancer Center

Endometrial cancer: Kimberly's story Roswell Park Comprehensive Cancer Center

Published: April 15, 2025, 12:16 p.m.
Cold atmospheric plasma drives USP49/HDAC3 axis mediated ferroptosis as a novel therapeutic strategy in endometrial cancer via reinforcing lactylation dependent p53 expression - Journal of Translational Medicine

Cold atmospheric plasma drives USP49/HDAC3 axis mediated ferroptosis as a novel therapeutic strategy in endometrial cancer via reinforcing lactylation dependent p53 expression Journal of Translational Medicine

Published: April 15, 2025, 11:54 a.m.
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer - OncLive

Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer OncLive

Published: April 14, 2025, 6:31 p.m.
VIDEO: Molecular profiling may soon guide endometrial cancer treatment decisions - Healio

VIDEO: Molecular profiling may soon guide endometrial cancer treatment decisions Healio

Published: April 14, 2025, 6:21 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!